InvestorsHub Logo

golf stud

07/20/23 8:04 PM

#412714 RE: mrmainstreet #412713

#1. 90% yes, if you said by June 2025 100%
#2. $25 a share (brave study very positive )

IslandOfMisfitToys

07/20/23 8:24 PM

#412717 RE: mrmainstreet #412713

No
N/A

Whalatane

07/20/23 8:37 PM

#412718 RE: mrmainstreet #412713

You need to add option 3)
3) No sale because no ones interested .....unless sales in the UK take off and they generate independent confirmation of at least some of the Reduce It trial results
Kiwi

rosemountbomber

07/20/23 8:41 PM

#412719 RE: mrmainstreet #412713

Mr. Main.

For #1, I have to think Yes if it does get sold it makes sense that it is not a whole bunch after that date as exclusivity erodes every day, and why would BP wait until there is no exclusivity.

#2, $7.50 a share.

#3 for Kiwi - 50% chance that no one is interested. For #1 I said by that date if there is to be a sale, but there is also a chance no one wants to take a flyer on Amarin (Vascepa).

MNBioMike

07/20/23 11:00 PM

#412726 RE: mrmainstreet #412713

No one wants this POS. If you were big pharma, why bother?